Bionano Genomics, Inc. - BNGO
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | — | A | A | 9,149.0 | 0.0 | 0.0 | 9,149.0 | View | |
| May 14, 2026 | — | A | A | 9,149.0 | 0.0 | 0.0 | 9,149.0 | View | |
| May 14, 2026 | — | A | A | 9,149.0 | 0.0 | 0.0 | 9,149.0 | View | |
| May 14, 2026 | — | A | A | 9,149.0 | 0.0 | 0.0 | 9,149.0 | View | |
| May 14, 2026 | — | A | A | 9,149.0 | 0.0 | 0.0 | 9,149.0 | View | |
| Feb 18, 2026 | CHIEF MEDICAL OFFICER | F | D | 18.0 | 1.1 | 19.8 | 644.0 | View | |
| Feb 18, 2026 | Principal Accounting Officer | F | D | 3.0 | 1.1 | 3.3 | 260.0 | View | |
| Feb 18, 2026 | GENERAL COUNSEL | F | D | 6.0 | 1.1 | 6.6 | 263.0 | View | |
| Feb 18, 2026 | CHIEF OPERATING OFFICER | F | D | 20.0 | 1.1 | 22.0 | 895.0 | View | |
| Feb 18, 2026 | PRESIDENT AND CEO | F | D | 51.0 | 1.1 | 56.1 | 1,657.0 | View | |
| Feb 04, 2026 | Principal Accounting Officer | A | A | 10,890.0 | 0.0 | 0.0 | 10,890.0 | View | |
| Feb 04, 2026 | CHIEF MEDICAL OFFICER | A | A | 27,737.0 | 0.0 | 0.0 | 27,737.0 | View | |
| Feb 04, 2026 | CHIEF OPERATING OFFICER | A | A | 27,737.0 | 0.0 | 0.0 | 27,737.0 | View | |
| Feb 04, 2026 | GENERAL COUNSEL | A | A | 26,117.0 | 0.0 | 0.0 | 26,117.0 | View | |
| Feb 04, 2026 | PRESIDENT AND CEO | A | A | 69,484.0 | 0.0 | 0.0 | 69,484.0 | View |